AAPL VS PACB Stock Comparison
Performance
AAPL100/100
100/100
AAPL returned 13.51% in the last 12 months. Based on SPY's performance of -13.31%, its performance is above average giving it a score of 100 of 100.
PACB66/100
66/100
PACB returned -17.61% in the last 12 months. Based on SPY's performance of -21.07%, its performance is above average giving it a score of 66 of 100.
Analyst Price Targets
AAPL78/100
78/100
38 analysts offer 12-month price targets for AAPL. Together, they have an average target of 190.63, the most optimistic target put AAPL at 240 within 12-months and the most pessimistic has AAPL at 110.
PACB67/100
67/100
6 analysts offer 12-month price targets for PACB. Together, they have an average target of 10.75, the most optimistic target put PACB at 14 within 12-months and the most pessimistic has PACB at 7.5.
Sentiment
AAPL70/100
70/100
AAPL had a bullish sentiment score of 70.31% across Twitter and StockTwits over the last 12 months. It had an average of 3,037.82 posts, 116,437.71 comments, and 721,824.29 likes per day.
PACB73/100
73/100
PACB had a bullish sentiment score of 72.66% across Twitter and StockTwits over the last 12 months. It had an average of 30.81 posts, 17.88 comments, and 57.50 likes per day.
Technicals
AAPL18/100
18/100
AAPL receives a 17 of 100 based on 14 indicators. 2 are bullish, 11 are bearish.
PACB18/100
18/100
PACB receives a 17 of 100 based on 14 indicators. 2 are bullish, 11 are bearish.
Earnings
AAPL100/100
100/100
AAPL has missed earnings 1 times in the last 20 quarters.
PACB10/100
10/100
PACB has missed earnings 7 times in the last 20 quarters.
Profit
AAPL76/100
76/100
Out of the last 20 quarters, AAPL has had 20 profitable quarters and has increased their profits year over year on 10 of them.
PACB19/100
19/100
Out of the last 20 quarters, PACB has had 3 profitable quarters and has increased their profits year over year on 3 of them.
Volatility
AAPL45/100
45/100
AAPL has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.
PACB58/100
58/100
PACB has had a higher than average amount of volatility over the last 12 months giving it a score of 58 of 100.
Dividend
AAPL50/100
50/100
AAPL's most recent dividend was $0.18 per share, based on a share price of $168.22. It was a payout ratio of 24.99% compared to their total earnings.
PACB
"Dividend" not found for PACB
All score calculations are broken down here to help you make more informed investing decisions
Apple Inc. Summary
Nasdaq / AAPL
Technology
Consumer Electronics
Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod. It also provides AppleCare support and cloud services; and operates various platforms, including the App Store that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts. In addition, the company offers various services, such as Apple Arcade, a game subscription service; Apple Fitness+, a personalized fitness service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It distributes third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. was incorporated in 1977 and is headquartered in Cupertino, California.
Pacific Biosciences of California, Inc. Summary
Nasdaq / PACB
Healthcare
Medical - Devices
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare AAPL to other companies in the same or a similar industry.